Carina Biotech Limited
February 26, 2024
Oncology
Carina Biotech is a clinical stage immuno-oncology company developing CAR-T and other adoptive cell therapies for the treatment of solid cancers.
In addition to its LGR5-targeted CAR-T cell therapy CNA3103 for advanced colorectal cancer, Carina has a deep pipeline of CAR-T programs as well as platform technologies for the positioning of CAR-T cells within solid tumours, to enhance potency and induce “serial” killing that is capable of memory and a proprietary 5-day manufacturing process.
)
){kind=logo}
)
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}